Login to Your Account

NewCo News: 3-V Bio Tackles Resistance with Host-Targeted Antivirals

By Trista Morrison

Tuesday, January 18, 2011
3-V Biosciences Inc. is among a handful of biotechs defying the conventions of antiviral drug development.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription